WHITEHAWK THERAPEUTICS, INC. (WHWK) Net margin 2018–2025
WHITEHAWK THERAPEUTICS, INC. (WHWK) net profit margin by fiscal year — reported net income divided by reported revenue.
-288.3%FY2025 · since FY2018: -51.6% → -288.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -288.3% | -43.1 pp |
| FY2024 | -245.1% | +24.9 pp |
| FY2023 | -270.0% | +127.7 pp |
| FY2022 | -397.7% | +388.7 pp |
| FY2021 | -786.4% | -761.5 pp |
| FY2020 | -24.8% | — |
| FY2018 | -51.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More WHWK financial trends
WHWK RevenueWHWK Net incomeWHWK Gross profitWHWK Gross marginWHWK Operating incomeWHWK Operating marginWHWK Operating cash flowWHWK Free cash flowWHWK Capital expendituresWHWK Return on equityWHWK Stock buybacksWHWK Dividends paidWHWK Total assetsWHWK Total liabilitiesWHWK Shareholders’ equityWHWK overview →